InvestorsHub Logo
Followers 88
Posts 6656
Boards Moderated 1
Alias Born 09/18/2009

Re: DonDonDonDon post# 35804

Thursday, 03/17/2022 11:44:11 AM

Thursday, March 17, 2022 11:44:11 AM

Post# of 42810
LOL ~~~ I'm worth every penny that I don't get paid.

I can't even explain how these mRNA vaccines, which showed 94-95% effectiveness 'preventing COVID-19 disease,' which was the basis for their EUA's, haven't been able to make Covid a distant memory.

For Immediate Release:
December 11, 2020


Pfizer EUA

FDA Takes Key Action in Fight Against COVID-19 By Issuing Emergency Use Authorization for First COVID-19 Vaccine

18,198 received the vaccine and 18,325 received placebo. The vaccine was 95% effective in preventing COVID-19 disease among these clinical trial participants with eight COVID-19 cases in the vaccine group and 162 in the placebo group. Of these 170 COVID-19 cases, one in the vaccine group and three in the placebo group were classified as severe.

https://www.fda.gov/news-events/press-announcements/fda-takes-key-action-fight-against-covid-19-issuing-emergency-use-authorization-first-covid-19

**********

December 21, 2020

Moderna’s COVID-19 Vaccine Gets EUA; Shipping Begins

The EUA was based on data from the placebo-controlled ‘COVE’ study that investigated the efficacy and safety of mRNA-1273 in more than 30,000 adults aged 18 years and older. Results as of November 21, 2020 showed that the vaccine was 94.1% effective based on 196 confirmed cases, of which 185 occurred in the placebo group and 11 occurred in the mRNA-1273 group.

https://www.empr.com/home/news/moderna-mrna-1237-emergency-use-disorder-eua-covid-19-vaccine/